AI-enabled medical devices with limited pre-market validation are more likely to be recalled after FDA clearance.
Key Details
- 1AI-enabled device recalls are more common among those lacking prospective human validation prior to FDA 510(k) clearance.
- 2Most AI medical devices are cleared without requiring prospective clinical testing.
- 3Study reviewed all U.S. recalls of AI-enabled devices between Nov. 15–30, 2024.
- 4Validation method (none, retrospective, or prospective) was a notable factor influencing recall likelihood.
- 5Recalls were categorized into errors such as diagnostic, measurement, and functional issues.
Why It Matters
These findings highlight the inadequacy of current FDA pathways to ensure AI device reliability and safety in clinical environments. For radiology professionals and developers, the results underscore the critical importance of robust validation before market approval.
Source
Health Imaging
Related News
•Radiology Business
AI Guidance Cuts Novice Ultrasound Exam Time by 34%
AI guidance significantly reduces exam times and enhances diagnostic quality for novice ultrasound operators performing shoulder exams.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.
•AuntMinnie
AI Algorithm Streamlines and Standardizes Shoulder Ultrasound Acquisition
A multitask AI system demonstrated high accuracy in standardizing and guiding shoulder musculoskeletal ultrasound imaging.